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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER1921cGMP Signaling and Phosphodiesterase-5 inhibitors in CardioprotectionRakesh C. Kukreja, Fadi N. Salloum, Anindita Das
Cycline guanosine monophosphate (cGMP) is an important intracellular second messenger
that mediates multiple tissue and cellular responses. Kukreja and colleagues review the cGMP
pathway as a key element in the pathophysiology of the heart. Modulation of this pathway
with drugs such as phosphodiesterase (PDE)-5 inhibitors and guanylate cyclase activators may
represent a promising therapeutic approach for acute myocardial infarction, cardiac
hypertrophy, heart failure, and doxorubicin cardiotoxicity in patients.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
1928Influence of Genetic Polymorphisms on the Effect of
High- and Standard-Dose ClopidogrelMatthew J. Price, Sarah S. Murray, Dominick J. Angiolillo, Elizabeth Lillie, Erin N. Smith,
Rebecca L. Tisch, Nicolas J. Schork, Paul S. Teirstein, Eric J. Topol, for the GIFT Investigators
This study by Price and colleagues evaluated the influence of single nucleotide polymorphisms
(SNPs) on the pharmacodynamic effect of high- or standard-dose clopidogrel in patients with
high on-treatment reactivity (OTR). Deoxyribonucleic acid samples obtained from over 1,000
subjects were genotyped for 41 SNPs in 17 genes. CYP2C19*2, associated with poor
metabolizers, was significantly associated with OTR at all time points from day 1 to 6
months. PON1, ABCB1 3435 C¡T, and other candidate SNPs were not. The portion of
the risk of persistently high OTR despite high-dose clopidogrel attributable to reduced-
function CYP2C19 allele carriage was 5.2%. In patients with high OTR despite high-dose
clopidogrel, CYP2C19 genotype provides limited incremental information.(continued on page A-19)
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1938Ivabradine Reduces Outcomes in Patients
With Chronic Heart Failure by Reducing Heart RateKarl Swedberg, Michel Komajda, Michael Böhm, Jeffrey Borer, Michele Robertson,
Luigi Tavazzi, Ian Ford, for the SHIFT Investigators
For this study, Swedberg and colleagues explored the interactions between beta-blocker dose
and the salutary effects of ivabradine. All patients had systolic heart failure, sinus rhythm, a
heart rate 70 beats/min, and were on maximally tolerated beta-blocker dose prior to the
addition of ivabradine. Heart failure hospitalizations were significantly reduced by ivabradine
in subjects at 50% of target beta-blocker dose. Further analyses showed that the magnitude
f heart rate reduction by beta-blocker plus ivabradine, rather than background beta-blocker
ose, determined the reduction in adverse events.ditorial Comment: Mohammad Sarraf, Gary S. Francis, page 1946HEART RHYTHM DISORDERS1948Dynamicity of the J-Wave in Idiopathic Ventricular FibrillationYoshifusa Aizawa, Akinori Sato, Hiroshi Watanabe, Masaomi Chinushi, Hiroshi Furushima,
Minoru Horie, Yoshiaki Kaneko, Tsutomu Imaizumi, Kimie Okubo, Ichiro Watanabe, Tsuyoshi Shinozaki,
Yoshiyasu Aizawa, Keiichi Fukuda, Kunitake Joo, Michel Haissaguerre
The J-wave can be found in apparently healthy subjects and in patients at risk for sudden
cardiac death. Aizawa and colleagues studied 40 patients with J-wave–associated idiopathic
ventricular fibrillation (VF) and 76 controls. J waves were defined as those 0.1 mV above
the isoelectric line. The J-wave was larger in patients with a history of idiopathic VF. The
J waves were augmented during storms of VF, decreased with isoproterenol infusion, and
disappeared within weeks in some patients. Pause-dependent augmentation of J waves was
detected in 56% of VF patients, and demonstrated high positive and negative predictive
values for identifying those who experienced VF.CARDIAC IMAGING1954MRI Imaging of Myocardial Oxygenation Adds New Insights Into CADJayanth R. Arnold, Theodoros D. Karamitsos, Paul Bhamra-Ariza, Jane M. Francis, Nick Searle,
Matthew D. Robson, Ruairidh K. Howells, Robin P. Choudhury, Ornella E. Rimoldi, Paolo G. Camici,
Adrian P. Banning, Stefan Neubauer, Michael Jerosch-Herold, Joseph B. Selvanayagam
By exploiting the paramagnetic properties of hemoglobin, blood oxygen level-dependent
(BOLD) magnetic resonance imaging (MRI) can differentiate areas of high and low oxygen
saturation. Arnold and colleagues applied BOLD and first-pass perfusion techniques to study
the relationship between coronary stenoses, perfusion, ventricular scar, and myocardial
oxygenation. BOLD imaging yielded an accuracy of 84% for detecting myocardial ischemia
and 86% for identifying significant coronary stenosis. However, on segment-based analysis,
there was only a weak correlation between areas of deoxygenation and hypoperfusion. Adding
a BOLD imaging sequence to cardiac MRI protocols may facilitate determining the
anatomical and functional significance of coronary artery disease (CAD).Editorial Comment: Jonathan W. Weinsaft, Pascal Spincemaille, page 1965
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1968No Evidence That Change in IE Prophylaxis Guidelines
Led to Higher Incidence of CasesXavier Duval, François Delahaye, François Alla, Pierre Tattevin, Jean-François Obadia,
Vincent Le Moing, Thanh Doco-Lecompte, Marie Celard, Claire Poyart, Christophe Strady,
Catherine Chirouze, Michelle Bes, Emmanuelle Cambau, Bernard Iung, Christine Selton-Suty,
Bruno Hoen, on behalf of the AEPEI Study Group
Duval and colleagues evaluated temporal trends in infective endocarditis (IE) incidence
following the change in French IE Prophylaxis Guidelines in 2002, which significantly
reduced the number of recommendations for IE prophylaxis. Three 1-year population-based
surveys were completed in 1991, 1999, and 2008 using the same techniques. IE incidence
remained stable over time in 32 to 35 cases per million residents. Oral streptococci IE
incidence did not increase either in the whole patient population or in patients with pre-
existing native valve disease. There was a significantly increased incidence of Staphylococcus
aureus IE in patients without previously known native valve disease. These results show that
scaling down antibiotic prophylaxis indications was not associated with an increased incidence
of oral streptococcal IE.Editorial Comment: Andrew Wang, page 1977PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH
1979Beta-3-Adrenergic Receptor Stimulation Is Protective
Against Pressure Overload in Mouse ModelTAC-BRLSHAM TAC TAC-BRL
Xiaolin Niu, Vabren L. Watts, Oscar H. Cingolani, Vidhya Sivakumaran, Jordan S. Leyton-Mange,
Carla L. Ellis, Karen L. Miller, Konrad Vandegaer, Djahida Bedja, Kathleen L. Gabrielson,
Nazareno Paolocci, David A. Kass, Lili A. Barouch
Beta-3-adrenergic receptors (ARs) are stimulated at high catecholamine concentrations and
may serve as a “brake” to protect the heart from catecholamine overstimulation. Niu and
colleagues investigated if activation of 3-AR would protect the heart in a mouse model of
pressure overload, transverse aortic constriction. Three weeks of 3-AR stimulation
attenuated cardiac ventricular dilation and systolic dysfunction. This effect was associated with
increased nitric oxide (NO) production and the cardioprotective effects were actually
detrimental in nNOS gene ablated mice. These results demonstrate the cardioprotective effect
of 3-AR specific agonism and the importance of nNOS in this pathway.Editorial Comment: Shathiyah Kulandavelu, Joshua M. Hare, page 1988
